Vaxtex Cotfab Limited has informed the Exchange regarding Board meeting held on August 05, 2025.
VCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vaxtex Cotfab's board, which met from 4:00 PM to 6:25 PM on August 5, 2025, approved unaudited standalone financial results for Q1 FY26 (quarter ended June 30, 2025). Revenue from operations stood at ₹525.33 lakhs and total income at ₹571.82 lakhs, with profit for the period at ₹21.60 lakhs versus ₹7.80 lakhs in the same quarter last year – roughly a 177% jump year-on-year. Basic and diluted EPS came in at ₹0.012, up from ₹0.004 in Q1 FY25. The board also approved the director's report for FY25, fixed the 20th AGM for September 2, 2025 via video conferencing, reconstituted the Audit, Nomination & Remuneration, and Stakeholder Relationship committees, and appointed Jay Pandya & Associates as secretarial auditor for a five-year term (FY 2025-26 to FY 2029-30). Statutory auditor SSRV & Associates issued an unmodified opinion on the Q1 results.
The strong year-on-year profit growth and clean (unmodified) audit opinion are positives for shareholders, though revenue was broadly flat. With the NCLT having recalled the CIRP against the company earlier in January 2025, these routine governance steps confirm the firm is fully operational under its board and should be read as stability signals rather than price-moving catalysts.